Continuous surveillance is essential to prevent cold weather injuries and mitigate their adverse impacts on military operations.

Common respiratory viruses are associated with substantial morbidity within the MHS.

Reportable Medical Events are documented in the Disease Reporting System internet by health care providers and public health officials throughout the MHS.

The U.S. Advisory Committee on Immunization Practices recommends influenza vaccination for all health care personnel, including MHS staff, to protect both themselves and their patients.

This report describes recent frequencies and rates of clinically-diagnosed sunburn among active component service members of the U.S. Armed Forces.

The emergence of mutant P. falciparum parasites in many malaria-endemic areas has led to false-negative results in all HRP2-detecting rapid diagnostic tests, undermining their critical utility, especially in deployment settings.

Complete and timely reporting of notifiable medical conditions among the Department of Defense (DOD) beneficiary population is important for the control of communicable and preventable diseases and injuries.

This report describes the incidence rate of colorectal cancer among active component U.S. military service members between 2010 and 2022.

This report provides an update through June 2023 of routine screening results for antibodies to HIV among members of the U.S. military. From January 2018 through June 2023, approximately 7 million U.S. military service members (active component, reserve component, and national guard) were tested for HIV antibodies; 1,502 were identified as HIV ...

Reportable Medical Events are documented in the Disease Reporting System internet by Military Health System providers and public health officials to monitor, control, and prevent the occurrence and spread of diseases of public health interest or readiness importance.

This Surveillance Snapshot presents the incidence of the 10 leading cancers among active component service members of the U.S. Armed Forces diagnosed from January 2018 through December 2022.

This is the first known study examining the rates of seropositivity for Ross River virus in a naïve U.S. Military population prior to an outbreak event, which identified a single seroconversion out of 628 deployed U.S. servcie members tested.